Scientist in the lab at Gladstone Institutes (IMAGE)

Gladstone Institutes

Scientist in the lab at Gladstone Institutes

Caption

A new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages of Alzheimer’s disease.

Credit

Photo: Michael Short/Gladstone Institutes

Usage Restrictions

Use for non commercial purposes only, with photo credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.